sulforaphane has been researched along with thromboxane a2 in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kim, SH; Mo, SJ; Oh, CH; Rhee, YH; Shin, JI; Yun, SJ | 1 |
| Chuang, WY; Kung, PH; Kuo, CY; Wu, CC | 1 |
2 other study(ies) available for sulforaphane and thromboxane a2
| Article | Year |
|---|---|
Antiplatelet activity of L-sulforaphane by regulation of platelet activation factors, glycoprotein IIb/IIIa and thromboxane A2.
Topics: Adenosine Diphosphate; Animals; Blood Coagulation; Blood Platelets; Collagen; Female; Fibrinolytic Agents; Humans; Isothiocyanates; Mice; Mice, Inbred ICR; Platelet Activation; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Pulmonary Embolism; Sulfoxides; Thiocyanates; Thrombin; Thromboxane A2 | 2013 |
Sulforaphane prevents human platelet aggregation through inhibiting the phosphatidylinositol 3-kinase/Akt pathway.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Animals; Blood Platelets; Calcium; Cattle; Enzyme Activation; Humans; Isothiocyanates; Phosphatidylinositol 3-Kinases; Platelet Aggregation; Platelet Aggregation Inhibitors; Protein Kinase C; Proto-Oncogene Proteins c-akt; Receptor, PAR-1; Signal Transduction; Sulfoxides; Thromboxane A2; Tyrosine; Vasoconstrictor Agents; Vegetables | 2013 |